DE3855801T2 - Anwendungsgebiete von beta-adrenergenen Agonisten - Google Patents

Anwendungsgebiete von beta-adrenergenen Agonisten

Info

Publication number
DE3855801T2
DE3855801T2 DE3855801T DE3855801T DE3855801T2 DE 3855801 T2 DE3855801 T2 DE 3855801T2 DE 3855801 T DE3855801 T DE 3855801T DE 3855801 T DE3855801 T DE 3855801T DE 3855801 T2 DE3855801 T2 DE 3855801T2
Authority
DE
Germany
Prior art keywords
beta
effects
adrenergic
reversing
adrenergic agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3855801T
Other languages
English (en)
Other versions
DE3855801D1 (de
Inventor
Charlotte Anne Maltin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rowett Research Institute
Original Assignee
Rowett Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878721602A external-priority patent/GB8721602D0/en
Priority claimed from GB888803619A external-priority patent/GB8803619D0/en
Application filed by Rowett Research Institute filed Critical Rowett Research Institute
Publication of DE3855801D1 publication Critical patent/DE3855801D1/de
Application granted granted Critical
Publication of DE3855801T2 publication Critical patent/DE3855801T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3855801T 1987-09-15 1988-09-12 Anwendungsgebiete von beta-adrenergenen Agonisten Expired - Lifetime DE3855801T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878721602A GB8721602D0 (en) 1987-09-15 1987-09-15 Therapeutic applications of beta-adrenergic agonists
GB888803619A GB8803619D0 (en) 1988-02-17 1988-02-17 Therapeutic applications of beta-adrenergic agonists

Publications (2)

Publication Number Publication Date
DE3855801D1 DE3855801D1 (de) 1997-04-03
DE3855801T2 true DE3855801T2 (de) 1997-07-03

Family

ID=26292734

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3855801T Expired - Lifetime DE3855801T2 (de) 1987-09-15 1988-09-12 Anwendungsgebiete von beta-adrenergenen Agonisten

Country Status (4)

Country Link
EP (2) EP0308157B1 (de)
AT (1) ATE149089T1 (de)
DE (1) DE3855801T2 (de)
ES (1) ES2100148T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203040B (en) * 1988-07-05 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing weight-increasing composition containing 1-(3,5-dihydroxy-phenyl)-2-(terc-butyl-amino)-ethanol
US5281623A (en) * 1990-08-27 1994-01-25 Eli Lilly And Company Method for treating inflammation
EP0488435A1 (de) * 1990-11-26 1992-06-03 Duphar International Research B.V Verfahren zur Steigerung des Muskel/Fett-Verhältnisses bei landwirtschaftlichen Nutztieren
US6524532B1 (en) 1995-06-20 2003-02-25 The Regents Of The University Of California Microfabricated sleeve devices for chemical reactions
US6015837A (en) * 1996-08-29 2000-01-18 New York Medical College Method for treating scoliosis with β2-adrenoceptor agonists
CA2455248A1 (en) * 2004-01-29 2005-07-29 Alexander Zolotoy Oral administration of r-albuterol against obesity
US8080528B2 (en) 2005-12-22 2011-12-20 The Releef Initiative Compositions and methods for treatment of cachexia
GB0625270D0 (en) * 2006-12-19 2007-01-31 Univ Leicester Angiogenesis
MX2009011294A (es) 2007-04-24 2010-01-29 Acacia Pharma Ltd Combinacion de farmacos y su uso en el tratamiento de la perdida muscular.
PL220308B1 (pl) 2011-06-03 2015-10-30 Kobel Buys Krystyna Zastosowanie klenbuterolu do leczenia objawów autyzmu dziecięcego oraz klenbuterol do zastosowania w leczeniu objawów autyzmu dziecięcego
JO3192B1 (ar) 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL60530A (en) * 1979-08-16 1984-10-31 American Cyanamid Co Animal feed compositions useful as growth promotors and for reduction of fat in animals,comprising phenylethanolamine derivatives and certain such novel compounds
UA8350A1 (uk) * 1983-01-31 1996-03-29 Елі Ліллі Енд Компані Спосіб годування сільськогосподарських тварин та птахів
GB8806471D0 (en) * 1988-03-18 1988-04-20 Tisdale M J Biologically active material characterised by catabolic activity generally associated with cachexia inducing tumours

Also Published As

Publication number Publication date
DE3855801D1 (de) 1997-04-03
EP0308157A2 (de) 1989-03-22
ES2100148T3 (es) 1997-06-16
EP0308157B1 (de) 1997-02-26
ATE149089T1 (de) 1997-03-15
EP0662324A1 (de) 1995-07-12
EP0308157A3 (de) 1992-01-15

Similar Documents

Publication Publication Date Title
ATE149089T1 (de) Anwendungsgebiete von beta-adrenergenen agonisten
DE69636278D1 (de) Inhibitor des muskelproteinabbaus enthaltend einen il-6 rezeptor antikörper
FR2496458B1 (fr) Composition huileuse destinee au traitement des matieres keratiniques et de la peau
DK46789D0 (da) 3-indolpyrodruesyrederivater og farmaceutisk anvendelse deraf
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
EP0401903A3 (de) Verwendung von Vanilloiden zur Behandlung von Erkrankungen der Atemwege
DE69022953D1 (de) Zusammensetzungen zur Behandlung von Fettablagerungen.
IL68350A0 (en) N-glycosylated carboxamide derivatives,their preparation and their use for the treatment of animals
ZA898605B (en) Compositions for topical treatment of skin diseases
DE3889974D1 (de) Pyrazol-Derivate und diese enthaltende Behandlungsmittel für cerebrovaskulare Krankheiten.
ATE107859T1 (de) Verwendung von antiprogestomimetika zur stimulierung des eisprungs.
BE884756A (fr) Composition dermatologique pour le traitement des maladies de la peau, accompagnees d'une proliferation cellulaire, telles que le psoriasis
FR2600256B1 (fr) Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus
ATE59780T1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
ZA822158B (de)
ZA873928B (en) Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease
FR2600531B1 (fr) Appareil pour le traitement d'etats pathologiques par stimulation de points d'acupuncture.
DE3374066D1 (en) N-acyl derivatives of peptides, their manufacture and use in combating diseases and means therefor
ATE197764T1 (de) Zusammensetzung zur behandlung des insulinmangels bei säugetieren, die amylin und insulin enthält.
ATE109349T1 (de) 3-substituierte-2-oxindolderivate als interleukin-biosynthesehemmer.
FR2529076B1 (fr) Dispositif pour le traitement therapeutique et stimulateur, combine, des gencives
ZA884315B (en) Combined use of an antigestagen and a progesterone synthesis inhibitor of the trilostane and epostane type
DE69118847T2 (de) Verwendung von Heptastigmin zur Behandlung der zerebralen Ictus
SU1797195A1 (ru) Способ профилактики радиационных поражений
ATE74755T1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-am no-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition